Article
Long Noncoding RNAs as Biotargets in Cisplatin-Based Drug Resistance
23 Nov 2018
Abstract excerpt
Since its discovery, cisplatin has become the key drug in chemotherapy for cancers. Nevertheless, chemoresistance in cancers has become an impediment in using cisplatin for cancer treatment. The resistance toward cisplatin is multifaceted as it involves multiple cellular pathways. Ever since the knowledge of long noncoding RNAs as modulators of various molecular pathways came to light, the interest in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
